Innovating Works

PATH-TOX

Financiado
JANSSEN PHARMACEUTICA NV
134.53K€ | Lider
VOSSLOH ESPANA
295.80K€ | Participante
PDS
293.13K€ | Participante
DECIPHEX LIMITED
1.63M€ | Participante